Attached files
file | filename |
---|---|
10-K - 10-K - NEVRO CORP | nvro-10k_20161231.htm |
EX-32.1 - EX-32.1 - NEVRO CORP | nvro-ex321_6.htm |
EX-31.2 - EX-31.2 - NEVRO CORP | nvro-ex312_7.htm |
EX-31.1 - EX-31.1 - NEVRO CORP | nvro-ex311_8.htm |
EX-21.1 - EX-21.1 - NEVRO CORP | nvro-ex211_564.htm |
EX-10.23(B) - EX-10.23(B) - NEVRO CORP | nvro-ex1023b_704.htm |
EX-10.22(B) - EX-10.22(B) - NEVRO CORP | nvro-ex1022b_706.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-211864) and Form S‑8 (Nos. 333-209816, 333-202857, and 333-200145) of Nevro Corp. of our report dated February 23, 2017 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 23, 2017